#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dermatomyositis Endometrial cancer Palmar-plantar erythrodysaesthesia syndrome Atypical haemolytic uraemic syndrome Neonatal alloimmune thrombocytopenia Alagille syndrome Glomerulonephritis acute T-cell type acute leukaemia Basal cell naevus syndrome Crigler-Najjar syndrome Systemic scleroderma Superficial vein thrombosis B precursor type acute leukaemia Small intestine neuroendocrine tumour Dilated cardiomyopathy More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Treatment Pemphigus – Basic Information Langerhans’ cell histiocytosis – Trials in Disease Haemophilia B with anti factor IX Cerebral arteriovenous malformation haemorrhagic – Diagnostics Ornithine transcarbamoylase deficiency – Treatment Chondrosarcoma metastatic – Diagnostics Alternating hemiplegia of childhood Soft tissue sarcoma – Basic Information Hairy cell leukaemia recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd2693 Sodium Depemokimab Peposertib Tralokinumab Zongertinib Pegargiminase Reboxetine Methionine Ticagrelor Cocarboxylase Tetrahydrate Cannabis Sativa Flower Tipranavir Damoctocog Alfa Pegol Carbamazepine (Ph. Eur.) SODIUM BENZOATE Tobramycin AZD4512 Gtaexs617 Immunoglobulin A Bictegravir More therapies…

    Learn about Your Condition

    Stevens-Johnson syndrome Cancer pain Retinopathy of prematurity Herpes zoster IgA nephropathy Adrenoleukodystrophy Hairy cell leukaemia Metastatic gastric cancer VEXAS syndrome Cystic fibrosis Blood disorder Neurofibromatosis Macular oedema Chondrosarcoma metastatic Asthmatic crisis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Obrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    Investigated Drugs:
    • Carboplatin
    • Etoposide
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    Austria Belgium Czechia Denmark Finland France +8

  • Lerodalcibep for Heterozygous Familial Hypercholesterolemia in Children and Adolescents 6 to 17 Years Old

    Recruiting

    3 1
    Investigated Drugs:
    • Lerodalcibep
    Norway

  • Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Multiple system atrophy
    Investigated Drugs:
    • 5,7-DICHLORO-2-((ETHYLAMINO)METHYL)-8-HYDROXY-3-METHYLQUINAZOLIN-4(3H)-ONE METHANESULFONATE
    France

  • Ifinatamab deruxtecan in Patients With Advanced Esophageal Squamous Cell Carcinoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    Czechia France Germany Norway

  • RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

    Recruiting

    3 1
    Czechia France Germany Hungary Italy Poland +2

  • GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

    Recruiting

    3 1
    Bulgaria Croatia Czechia Germany Greece Hungary +4
Previous Page
1 … 15 16 17 18 19 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!